Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma

Thorax

Volumn 57, Issue 10, 2002, Pages 880-884

  Suissa, Samy ^a   Ernst, P ^a,b   Kezouh, A ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN HYDROGEN TARTRATE; BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; FLUNISOLIDE; IPRATROPIUM BROMIDE; ISOPRENALINE; KETOTIFEN; NEDOCROMIL; ORCIPRENALINE; PROCATEROL; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE DERIVATIVE; TRIAMCINOLONE ACETATE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; HOSPITALIZATION; HUMANS; LONG-TERM CARE; PATIENT READMISSION; RECURRENCE; TREATMENT OUTCOME;

EID: 0036794844     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.10.880     Document Type: Article

References (36)

1. Barnes PJ. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol 1998;101:S427-33.
2. Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 1990;85:1098-111.
3. Boulet L-P, Becker A, Bérubé D, et al. Summary of recommendations from the asthma consensus report, 1999. Can Med Assoc J 1999;161:s1-12.
4. National Heart, Lung and Blood Institute. New NHLBI guidelines for the diagnosis and management of asthma. Lippincott Health Promot Lett 1997;2:1, 8-1, 9.
5. International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-32.
6. Sears MR. Epidemiological trends in asthma. Can Respir J 1996;3:261-8.
7. Sunyer J, Anto JM, Tobias A, et al. Generational increase of self-reported first attack of asthma in fifteen industrialized countries. European Community Respiratory Health Study (ECRHS). Eur Respir J 1999;14:885-91.
8. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001;107:937-44.
9. Suissa S, Ernst P, Benayoun B, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
10. Gergen PJ, Weiss KB. Changing patterns of asthma hospitalization among children: 1979 to 1987. JAMA 1990;264:1688-92.
11. Gerstman BB, Bosco LA, Tomita DK. Trends in the prevalence of asthma hospitalization in the 5- to 14-year-old Michigan Medicaid population, 1980 to 1986. J Allergy Clin Immunol 1993;91:838-43.
12. Horwood LJ, Dowson KP, Mogridge N. Admission patterns for childhood acute asthma: Christchurch 1974-89. NZ Med J 1991;104:277-9.
13. Strachan DP, Anderson HR. Trends in hospital admission rates for asthma in children. BMJ 1992;304:819-20.
14. Hyndman SJ, Williams DR, Merrill SL, et al. Rates of admission to hospital for asthma. BMJ 1994;308:1596-600.
15. Centers for Disease Control and Prevention. Asthma mortality and hospitalization among children and young adults: United States, 1980-1993. JAMA 1996;275:1535-7.
16. Wilkins K, Mao Y. Trends in rates of admission to hospital and death from asthma among children and young adults in Canada during the 1980s. Can Med Assoc J 1993;148:185-90.
17. Smith DH, Malone DC, Lawson KA, et al. A national estimate of the economic costs of asthma. Am J Respir Crit Core Med 1997;156:787-93.
18. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992;326:862-6.
19. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 2000;106:493-9.
20. Krahn MD, Berka C, Langlois P, et al. Direct and indirect costs of asthma in Canada, 1990. Can Med Assoc J 1996;154:821-31.
21. Rea HH, Scrogg R, Jackson R, et al. A case-control study of deaths from asthma. Thorax 1986;41:833-9.
22. Grainger J, Woodman K, Pearce N, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 1991;46:105-11.
23. Crane J, Pearce N, Burgess C, et al. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 1992;21:737-44.
24. Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149:604-10.
25. Tough SC, Green FH, Paul JE, et al. Sudden death from asthma in 108 children and young adults. J Asthma 1996;33:179-88.
26. Mitchell EA, Bland JM, Thompson JM. Risk factors for readmission to hospital for asthma in childhood. Thorax 1994;49:33-6.
27. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-91.
28. Blais L, Ernst P, Boivin JF, et al. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998;158:126-32.
29. Blais L, Suissa S, Boivin JF, et al. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 1998;53:1025-9.
30. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000;343:1064-9.
31. Anonymous. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000;343:1054-63.
32. Strand LM, Downey W. Health databases in Saskatchewan. In: Strom BL, ed. Pharmacoepidemiology. New York: John Wiley, 1994: 217-29.
33. Lubin JH, Gail MH. Biased selection of controls for case-control analyses for cohort studies. Biometrics 1984;40:63-75.
34. Freund DA, Stein J, Hurley R, et al. Specialty differences in the treatment of asthma. J Allergy Clin Immunol 1989;84:401-6.
35. Cochrane GM. Compliance and outcomes in patients with asthma. Drugs 1996;52:12.
36. Cochrane GM, Horne R, Chanez P. Compliance in asthma. Respir Med 1999;93:763-9.